BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

Free Newsletters
My Subscriptions

News by Subject
News by Disease
News by Date
Search News
Post Your News

Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Pharm Country
  Bio NC
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™


Company Profiles

Research Store

Research Events
Post an Event
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
BioPharm Executive - Career Track
Ex-Teva (TEVA) CEO Becomes Chief of Start-Up Ovid Therapeutics As Orphan Drugs Come Into Focus 4/16/2015
Valeant (VRX) Exec's $50.6 Million Paycheck Makes Him the Second Highest Paid Non-CEO Employee 4/14/2015
Amgen (AMGN) CEO Gets $14M Payday, But Colleagues Who Took Pay Cuts May Disagree 4/10/2015
Is Gilead (GILD) CEO Worth The Money? 4/8/2015
Sarepta (SRPT) CEO Resigns Abruptly, Was "In Over His Head" 4/6/2015
Allergan (AGN) CEO Pyott Out But Don't Fret, He May Have Landed His Next Gig Already 3/19/2015
23andMe Dives Into Biotech With Ex-Genentech (RHHBY) R&D Star at Helm 3/18/2015
Acadia (ACAD) Tanks as Key Drug is Delayed, CEO Resigns 3/16/2015
After Turning Down Sanofi (SAN.PA) Gig, Takeda (TKPYY) COO Gets Promoted to CEO 3/5/2015
GlaxoSmithKline (GSK) CEO's Pay Cut by 46% as Profits Decline 3/2/2015
Sanofi (SAN.PA) Officially Names Paris-Educated Brandicourt as New CEO 2/23/2015
Ariad (ARIA) Touts Impressive Financials But Investors Still Push for CEO Ouster 2/23/2015
GlaxoSmithKline (GSK) Replaces Head of Struggling U.S. Operations 2/18/2015
Hospira CEO May Walk Away With More Than $80 Million After Pfizer (PFE) Deal is Finalized 2/12/2015
FDA Commissioner to Step Down After Six Years 2/6/2015
Scandal-Hit GlaxoSmithKline (GSK) to Chop 1,000 Staffers in China 1/27/2015
Takeda (TKPYY) COO Was Approached for Sanofi (SAN.PA) CEO Job But Declined 1/23/2015
Ousted Sanofi (SAN.PA) CEO Pockets $5 Million+ Severance Package 1/23/2015
Bristol-Myers Squibb Company (BMY) Names Caforio As New CEO Effective May 5 1/22/2015
Aegerion (AEGR) Stays Mum as Top Investors Push to Oust CEO, Consider Sale 1/20/2015
Genentech (RHHBY)'s R&D Chief To Retire; Small Molecule Head Takes Over Top Spot 12/16/2014
Ex-Wyeth (WYE) Head Out Of The Running For Sanofi (SAN.PA) CEO Gig 12/15/2014
Regeneron (REGN) CEO Says He's Sticking To Plan To Double NY Workforce, Lauds Funding "Halo" 12/15/2014
Mylan Inc. (MYL) To Pay Five Top Execs $32.5 Million Earlier Than Planned As Drugmaker Exits U.S. 12/11/2014
AstraZeneca PLC (AZN) Will Invest $200M, Add 300 Jobs In Maryland Plant Expansion 11/24/2014
Oxford Pharmaceuticals Plans New U.S. Location With 200 Jobs 11/19/2014
Johnson & Johnson (JNJ)'s McNeil Consumer Healthcare May Shutter 800 Employee Plant 11/6/2014
Amgen (AMGN) Now Expects Job Cuts To Exceed 2,900 10/30/2014
Sanofi (SAN.PA) Approached AstraZeneca PLC (AZN)'s Soriot For CEO Role 10/30/2014
Sanofi (SAN.PA) Mulls Firing CEO Viehbacher 10/29/2014
Amgen (AMGN) Lays Off 274 Employees As Part Of Its Exit From Washington State 10/27/2014
Gilead Sciences, Inc. (GILD) To Create More Than 80 Jobs With $50 Million Expansion 10/23/2014
Ex-Dendreon Corporation (DNDN) CEO Gold Working On New Cancer Drug Startups 10/14/2014
Retrophin (RTRX) Booted CEO For Multiple Stock Violations: Report 10/6/2014
Merck KGaA (MKGAF.PK) Appoints New Deputy Chief As CEO Kley’s Succession Is Pondered 9/18/2014
Agilent Technologies Inc. (A) Announces CEO Transition: Mike Mcmullen To Succeed Bill Sullivan In March 2015 9/18/2014
Google Inc.'s Calico To Hire As Many As 150 Staffers; Some May Be Current Genentech (RHHBY) Employees 9/12/2014
Genzyme Corporation (GENZ) To Move 500-Employees To New Space In Westborough 9/8/2014
Shareholders Revolt Over GlaxoSmithKline (GSK)'s Plans To Shake Up Board; Investors Call For Speedy Departure Of Chairman Gent 9/2/2014
More Exits From Ranbaxy Laboratories (RANBAXY.BO)' Top Management Team 8/21/2014
Allergan Inc. (AGN) CFO Steps Down In Midst Of Hostile Takeover Bid By Valeant Pharmaceuticals International (VRX) 8/20/2014
Boehringer Ingelheim Corporation Goes On A Hiring Freeze And Plans To Chop Jobs 8/14/2014
Handpicked By Ex-CEO, Takeda Pharmaceutical Co. Ltd. (TKPYY)'s New Leader Vows To Remain Japanese-Based, Will Attempt To Get Company Out Of Slump 8/12/2014
More Drama At Sarepta Therapeutics (SRPT) As Chairman Of The Board Abruptly Steps Down, Interim Chairman Named 8/1/2014
Sarepta Therapeutics (SRPT) Terminates Chief Science Officer As It Heads Toward Drug Approval 7/25/2014
Merck & Co., Inc. (MRK) Cuts Another 600 Sales Reps 7/25/2014
Eli Lilly and Company (LLY) To Cut Up To 100 Indy Jobs, Send Some Work Overseas 7/23/2014
Teva Pharmaceutical Industries Limited (TEVA) Denies Shareholder Claim That A Chairman Has Been Selected 7/15/2014
Merck KGaA (MKGAF.PK) Hires A New Global Head Of R&D 7/15/2014
Dr. Reddy's Laboratories Ltd. (RDY) To Dump $320 Million In Biologics, Proprietary Medicines 6/20/2014
With Boardroom Drama Behind Him, Teva Pharmaceutical Industries Limited (TEVA) Chairman Phillip Frost To Step Down By End Of The Year 6/19/2014
Valeant Pharmaceuticals International (VRX) Senior Executive Leaves Amidst Allergan Inc. (AGN) Takeover Battle 6/17/2014
Booming Moderna Therapeutics, Inc. Doubles Footprint In Cambridge Due To Rapid Growth 6/13/2014
Novo Nordisk A/S (NVO) To Hire 6,000 New Employees In Denmark By 2022 6/13/2014
Dieter Weinand Tapped To Be President Of Bayer HealthCare Pharmaceuticals (BAYA.F) 6/6/2014
Organization Changes At Celgene (CELG) Have Got Investors Wondering Who Will Take Over Once Hugin Steps Down 5/23/2014
Alcon Laboratories, Inc. (ACL) Slashes Headcount By 200 5/19/2014
AcelRx Pharmaceuticals (ACRX) Triples Headcount, Expands Bay Area Facility 5/19/2014
Gilead Sciences, Inc. (GILD) Shareholders Decimate Plan To Tie CEO Compensation To Drug Access 5/9/2014
Teva Pharmaceutical Industries Limited (TEVA) To Speed Up Cost-Cutting Plans, Layoffs And Facility Shutdowns On The Horizon 5/7/2014
AstraZeneca PLC (AZN) Investors Enraged, Revolt Over Executive Pay Plans 4/28/2014
Alexion Pharmaceuticals Inc. (ALXN) CEO Racks Up $30 Million Salary In 2013 4/24/2014
Novartis AG (NVS) Deal Makes GlaxoSmithKline (GSK)'s Pennsylvania Staffers Nervous 4/23/2014
AbbVie (ABBV) Moving Up To 2,000 Workers Off Abbott Laboratories (ABT) Campus 4/22/2014
Pfizer Inc. (PFE) CEO Takes On Additional Role, Becomes PhRMA Board Chairman 4/11/2014
Johnson & Johnson (JNJ) Taps Industry's First Tech-Savvy Chief Design Officer 3/21/2014
Entrepreneur Seamus Mulligan Cashes In $86 Million Of Jazz Pharmaceuticals plc (JAZZ) To Fund New Venture 3/21/2014
In Another Top Management Move, Takeda Pharmaceutical Co. Ltd. (TKPYY) Appoints New Emerging Markets Chief 3/20/2014
Indian Firms Warm Up To Ireland, Could Create 1,000 More Jobs 3/19/2014
Gilead Sciences, Inc. (GILD) Chief: $180 Million Man 3/19/2014
Biogen Idec (BIIB) Taps Papadopoulos As Its Chairman, Replacing Young 2/17/2014
Ex-Gilead Sciences, Inc. (GILD) Exec Takes Job At Alexion Pharmaceuticals Inc. (ALXN) In Ireland 2/11/2014
Another 550 AstraZeneca PLC (AZN) Jobs Axed 2/7/2014
Novartis AG (NVS)'s Cost-Cutting Move Affects Up To 4,000 Jobs 2/4/2014
AstraZeneca PLC (AZN) To Shutter Indian R&D Site; To Impact 170 Jobs 1/29/2014
Lexicon Pharmaceuticals, Inc. (LXRX) Axes 45 Percent Of Jobs, CEO To Step Down 1/14/2014
First Gilead Sciences, Inc. (GILD), Now Amgen (AMGN) Loses A Top Exec 1/13/2014
Novartis AG (NVS) Head, Herve Hoppenot, Flys The Coop To Become CEO Of Incyte Corporation (INCY) 1/13/2014
Teva Pharmaceutical Industries Limited (TEVA) Confirms Rumor, Picks Turnaround Specialist As New CEO 1/9/2014
Gilead Sciences, Inc. (GILD)'s Head Of Commercial Operations To Step Down 1/8/2014
Optimer Pharmaceuticals, Inc. (OPTR) Chops 177 New Jersey Staffers 12/6/2013
Takeda Pharmaceutical Co. Ltd. (TKPYY) Names GlaxoSmithKline (GSK) Exec For Top Post 12/3/2013
Forest Laboratories, Inc. (FRX) To Trim Jobs In $500 Million Restructuring 12/2/2013
Eisai Company, Ltd. (ESALY.PK)'s R&D Organization Undergoes "Transformation," Chops 130 Jobs 12/2/2013
Merck & Co. (MRK) To Shutter Irish Plant, 570 Jobs To Go 12/2/2013
Google Inc.'s Calico Snags Big Biotech Names: Ex-Genentech (RHHBY) Exec Barron, Top Scientist Botstein 11/20/2013
Bristol-Myers Squibb Company (BMY) Shakes Up Senior Management Team 11/18/2013
Novartis AG (NVS) to Beef Up Cambridge Site With 175 New Jobs, Slashes 500 R&D Jobs Elsewhere 11/8/2013
Ariad Pharmaceuticals, Inc. (ARIA) Chops 40 Percent of Workforce in the U.S. 11/8/2013
Teva Pharmaceutical Industries Limited (TEVA) CEO Resigns After Reported Feud With Chairman 10/31/2013
Amarin Corporation PLC (AMRN) Slashes Half Its Staff After FDA Panel Scraps Fish-Oil Pill Expansion 10/23/2013
Roche (RHHBY) to Spend $880 Million in Biologics Future; Will Inject $285 Million Into Genentech (RHHBY)'s Vacaville, Oceanside Sites, Create 250 New Jobs 10/15/2013
Teva Pharmaceutical Industries Limited (TEVA) Plans to Cut About 5,000 Employees 10/11/2013
Boehringer Ingelheim Corporation's Ben Venue Laboratories to Shut Down Operations Permanently; 1,100 Staffers Handed Pink Slips 10/7/2013
Merck & Co., Inc. (MRK) Slashes 8,500 Jobs to Save $2.5 Billion 10/2/2013
Bayer AG (BAYN.DE) to Hire 800 in Russia Over the Next Four Years 9/10/2013
Forest Laboratories, Inc. (FRX) Names Brent Saunders CEO and President 9/10/2013
Rigel Pharmaceuticals, Inc. (RIGL) Axes 18 Pct of Workforce, Ends Some Drug Programs 9/6/2013
Onyx Pharmaceuticals, Inc. (ONXX) CEO Could Snag $62 Million if He Leaves After Amgen (AMGN) Takeover 9/5/2013
Newly Named VIVUS, Inc. (VVUS) CEO Resigns Due to Health Concerns, Ex-Johnson & Johnson (JNJ) Exec to Take Over 9/4/2013
Regeneron Pharmaceuticals, Inc. (REGN) Planning to Add 85 Jobs 8/23/2013
Boehringer Mannheim Corporation's Ben Venue Laboratories to Trim Hundreds of Jobs, Will Cut Production Activity by Year's End 8/21/2013
Bill & Melinda Gates Foundation Lures Biotech VC to Work on Global Health Startups 8/15/2013
Lundbeck Inc. (LUN.CO) to Hire More Than 200 Reps to Market Brintellix 8/8/2013
New VIVUS, Inc. (VVUS) CEO to Focus on Retail Push for Diet Pill 8/7/2013
Roche (RHHBY) Takes Its Hunt for a New Chairman Further Afield 7/22/2013
Bristol-Myers Squibb Company (BMY) to Bring 579 New Jobs to FL 7/22/2013
Notice Regarding Transfer of Shares of Eisai Company, Ltd. (ESALY.PK) Subsidiary 7/19/2013
Bitter Pfizer Inc. (PFE) Fight Ends With Ex-Onyx Pharmaceuticals, Inc. (ONXX) Exec as New Chief 7/19/2013
AstraZeneca PLC (AZN) CFO Jumps Ship to BG Group 7/15/2013
AstraZeneca PLC (AZN) Announces New $500 Million Cambridge Biomedical Campus HQ, Will Employ 2000 by 2016 6/19/2013
Alexion Pharmaceuticals Inc. (ALXN) to Break Ground on $100 Million Headquarters, Will Create 200-300 New Jobs 6/19/2013
New Millennium Chief Faces Questions and Uncertainties, Acknowledges Takeda Pharmaceutical Co. Ltd. (TKPYY) Restructuring May Lead to Job Cuts 6/18/2013
GlaxoSmithKline (GSK) Fires Head of Its Chinese R&D Unit for Data Fraud 6/12/2013
The AbbVie (ABBV) Culture Change Continues: 100 Scientists Will be Laid Off 6/3/2013
Forest Laboratories, Inc. (FRX) CEO Solomon Finally Listens to Carl Icahn and Will Retire 5/23/2013
Ranbaxy Laboratories (RANBAXY.BO) Rumored to Cut One-Third of Global Sales Force, Mainly in U.S.: Source 5/23/2013
AstraZeneca PLC (AZN) Closes in on Site for New $500 Million Home in Cambridge 5/22/2013
Third Rock Ventures Taps Alnylam Pharmaceuticals (ALNY) CEO, Genzyme Corporation (GENZ)-ImClone Systems (LLY) Vets, as Venture Partners 5/14/2013
Millennium Pharmaceuticals, Inc. CEO Out as Takeda Pharmaceutical Co. Ltd. (TKPYY) Reorganizes, Cuts Costs 5/13/2013
Fresh on the Market AbbVie (ABBV) Axing Hundreds of Jobs to Deal With Patent Losses 4/16/2013
Eli Lilly and Company (LLY) Plans to Lay Off 30 Pct of Its Sales Reps 4/15/2013
Bristol-Myers Squibb Company (BMY) to Spend $250 Million to Expand Biologics Facility, Increase Workforce by 350 4/11/2013
New Amgen (AMGN) CEO Doubles His Salary in First Year 4/9/2013
Eli Lilly and Company (LLY) to Spend $260 Million on Indianapolis Expansion, Will Hire Hundreds 4/2/2013
AstraZeneca PLC (AZN): 2300 More Layoffs; Global Total Now 5050 3/22/2013
Compensation Jumps 43 Pct for AbbVie (ABBV) CEO 3/19/2013
Affymax, Inc. (AFFY) May File for Bankruptcy; Cuts 75 Pct of Workforce 3/19/2013
Johnson & Johnson (JNJ) Cuts Executive Bonuses, Citing "Disappointments" 3/14/2013
Performance Pay Package Halved for GlaxoSmithKline (GSK) CEO 3/7/2013
Genentech (RHHBY) Expected to Hire 600 New Employees, Bay Area Included 3/4/2013
Teva Pharmaceutical Industries Limited (TEVA) to Sell California Plant as Part of Cost Cutting 2/8/2013
Pfizer Inc. (PFE) Closes Clinical Research Unit in Singapore 2/8/2013
Amgen (AMGN) to Cut 160 Jobs 2/4/2013
AstraZeneca PLC (AZN) Fails to Rule Out Job Cuts as Profits Plunge 2/1/2013
Novartis AG (NVS) Slashes CEO, Chairman Pay; Vasella Steps Down 1/24/2013
MedImmune (AZN) Execs Shuffled After AstraZeneca PLC (AZN) Shakeup, Unit Split in 3 1/22/2013
Forest Pharmaceuticals Breaks Ground in Ohio, Will Create 125 New Jobs 1/21/2013
Job Cut Fears at AstraZeneca PLC (AZN)'s Research Hub 1/15/2013
The Long Goodbye: as Drug Giant Roche (RHHBY) Exits Nutley, What Comes Next for Sprawling Site? 1/14/2013
Billionaires Push to Turn Ex-Merck Serono HQs Into R&D Center, New Jobs 12/11/2012
Roche (RHHBY) CEO's Proposed Election to Board Criticised 12/10/2012
Pfizer Inc. (PFE) and the Incredible Shrinking Sales Force 12/7/2012
Controversial FDA Official Tom Laughren Retires 12/7/2012
AstraZeneca PLC (AZN) to Cut 625 Jobs 12/6/2012
Celgene (CELG), Sanofi (France) (SAN.PA) Executives Charged With Insider Trading 11/20/2012
Targacept, Inc. (TRGT) Appoints Stephen A. Hill, M.D., President and CEO 11/15/2012
Regeneron Pharmaceuticals, Inc. (REGN) to Add 300 Jobs in New York 11/15/2012
Gilead Sciences, Inc. (GILD) Quietly Plans Expansion, to Hire R&D Staff 11/14/2012
The Axe Falls: Bristol-Myers Squibb Company (BMY) to Cut Nearly 500 Jobs 11/7/2012
Johnson & Johnson (JNJ) Cuts 130 Jobs After Alzheimer Drug Fails 10/25/2012
CORTEX Plans $186 Million in New Biotech Development; 1,400 New Jobs 10/23/2012
Abbott Laboratories (ABT) Lays Off 550, More Cuts to Come 10/22/2012
Merck & Co., Inc. (MRK) Moves Global HQs to Cut Expenses, Consolidate Properties 10/10/2012
Cipla Ltd. CEO Resigns to Avoid Hearing 10/8/2012
Roche (RHHBY) Picks NYC for New R&D Site 9/21/2012
Johnson & Johnson (JNJ) Starts 4 Innovation Centers to Scope for Early-Stage Acquisitions, Licensing Deals 9/19/2012
Merck KGaA (MKGAF.PK) to Axe 1,100 Jobs in Germany 9/5/2012
Teva Pharmaceutical Industries Limited (TEVA) Chair Should Fly Business Class: Shareholder 9/5/2012
AstraZeneca PLC (AZN) Grabs Roche (RHHBY) Pharma Head as New CEO 8/29/2012
Abbott Laboratories (ABT) Rebukes CEO Salary Study 8/21/2012
Cipla Medpro Suspends CEO for "Serious" Charges 8/16/2012
Icahn May Win One Board Seat at Forest Laboratories, Inc. (FRX) 8/15/2012
Ex-Pfizer Inc. (PFE) Chief, Joins VC Firm Lux Capital 8/10/2012
Baxter International, Inc. (BAX) Facility to Create 1,500 New Jobs 8/3/2012
FDA Spied on Its Own Scientists 7/17/2012
AstraZeneca PLC (AZN)'s Ex-CEO Forfeits 2012 Bonus 7/16/2012
Forest Laboratories, Inc. (FRX) Hires Search Firm to Hunt for New CEO 7/11/2012
QLT Inc. (QLTI) Slashes Workforce by Two-thirds, CEO Quits After Shareholder Coup 7/10/2012
Roche (RHHBY) to Cut 1,000 Research Jobs in U.S. 6/27/2012
Alexion Pharmaceuticals Inc. (ALXN) to Create 300 New Jobs, Establishes $100 Million Global HQ in New Haven 6/21/2012
Icahn Nominates Four for Forest Laboratories, Inc. (FRX) Board in Second Fight 6/20/2012
Lundbeck Inc. (LUN.CO) to Cut 600 Jobs in Europe to Contain Costs 6/14/2012
Chelsea Therapeutics, Inc. (CHTP) Cuts Exec Pay by 25% & Suspends Bonuses 6/8/2012
Targacept, Inc. (TRGT)'s Chief Executive deBethizy Steps Down in Shake-Up 6/4/2012
PPD, Inc. (PPDI) Names David Simmons Chairman and CEO 5/23/2012
GenVec Inc. (GNVC) Appoints Cynthia Collins as President and CEO 5/21/2012
Allergan Inc. (AGN) to Build R&D Plant, Add 400 Jobs in New Jersey 5/18/2012
AMAG Pharmaceuticals, Inc. (AMAG) Appoints William Heiden as President and Chief Executive Officer 5/10/2012
AstraZeneca PLC (AZN)'s Exiting CEO Reportedly in Line for $65 Million "Golden Goodbye" 4/30/2012
Baxter International, Inc. (BAX)'s $1 Billion Plant to Bring 1,500 High-paying Jobs to Metro Atlanta 4/19/2012
New Teva Pharmaceutical Industries Limited (TEVA) CEO May Dilute R&D 4/13/2012
Former Vertex Pharmaceuticals (MA) (VRTX) CEO Saw 10 Percent Pay Cut 4/12/2012
Some AstraZeneca PLC (AZN) Investors Want CEO Replaced 4/10/2012
Optimer Pharmaceuticals, Inc. (OPTR) Strips Chairman of Title, Fires CFO and Another Exec 4/10/2012
Outgoing Amgen (AMGN) CEO May Receive $49 Million After Retirement 3/26/2012
GlaxoSmithKline (GSK) to Create 1,000 New Jobs in $793.7 Million Investment 3/23/2012
Abbott Laboratories (ABT) CEO, Execs See Pay Cut; Pfizer Inc. (PFE)'s Chief Ian Read's Pay Triples First Year on Job 3/16/2012
Stemline Therapeutics, Inc. Appoints Kevin Buchi, Former CEO of Cephalon, Inc. (CEPH), to Its Board of Directors 3/15/2012
Sanofi (France) (SAN.PA) CEO: Who Needs Big Pharma Scientists? 3/5/2012
Procter & Gamble (PG) to Slash 5,700 Jobs and Cut Costs by $10 Billion 2/27/2012
Johnson & Johnson (JNJ) CEO Weldon Out, Successor Named 2/24/2012
GlaxoSmithKline (GSK) to Cut 3 Discovery Performance Units (DPUs), Will Add 4 New Units as Focus Shifts to R&D Productivity 2/8/2012
AstraZeneca PLC (AZN) to Axe 7,300 Jobs in Global Restructuring 2/3/2012
Dendreon Corporation (DNDN) Taps Savient Pharmaceuticals, Inc. (SVNT)'s Johnson as CEO 2/1/2012
Takeda Pharmaceuticals Plans to Reduce Europe, U.S. Workforce by 2,800 Jobs 1/19/2012
Quintiles, Inc. (QTRN) to Hire 500 in China 1/19/2012
Novartis AG (NVS) Cuts 2,000 U.S. Jobs After Drug Setback 1/17/2012
Human Genome Sciences, Inc. (HGSI) to Cut 150 Jobs Amid Modest Benlysta Growth 1/10/2012
Teva Pharmaceutical Industries Limited (TEVA) Taps Bristol-Myers Squibb Company (BMY) Exec as New CEO; Appointment Hints at More Acquisitions to Come 1/3/2012